COSMOS Pharmaceutical Corporation (3349.T)
JPY 6521.0
(-1.63%)
JPY 6521.0
(-1.63%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 24.45 Billion JPY | 2.76% |
| 2022 | 23.79 Billion JPY | 2.77% |
| 2021 | 23.15 Billion JPY | -14.73% |
| 2020 | 27.15 Billion JPY | 26.69% |
| 2019 | 21.43 Billion JPY | 11.73% |
| 2018 | 19.18 Billion JPY | 8.8% |
| 2017 | 17.63 Billion JPY | -3.2% |
| 2016 | 18.21 Billion JPY | 46.48% |
| 2015 | 12.43 Billion JPY | 6.34% |
| 2014 | 11.69 Billion JPY | 10.32% |
| 2013 | 10.6 Billion JPY | 12.81% |
| 2012 | 9.39 Billion JPY | 21.44% |
| 2011 | 7.73 Billion JPY | 34.86% |
| 2010 | 5.73 Billion JPY | 21.75% |
| 2009 | 4.71 Billion JPY | 65.86% |
| 2008 | 2.84 Billion JPY | 30.74% |
| 2007 | 2.17 Billion JPY | -5.48% |
| 2006 | 2.29 Billion JPY | 18.26% |
| 2005 | 1.94 Billion JPY | 54.41% |
| 2004 | 1.25 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 8.14 Billion JPY | 14.74% |
| 2023 Q1 | 6.5 Billion JPY | -13.39% |
| 2023 Q4 | 7.09 Billion JPY | 23.0% |
| 2023 Q3 | 5.77 Billion JPY | 13.61% |
| 2023 FY | 24.45 Billion JPY | 2.76% |
| 2023 Q2 | 5.07 Billion JPY | -21.96% |
| 2022 Q4 | 7.51 Billion JPY | 50.76% |
| 2022 FY | 23.79 Billion JPY | 2.77% |
| 2022 Q3 | 4.98 Billion JPY | 3.45% |
| 2022 Q2 | 4.81 Billion JPY | -25.66% |
| 2022 Q1 | 6.48 Billion JPY | -3.27% |
| 2021 Q1 | 6.24 Billion JPY | 11.98% |
| 2021 FY | 23.15 Billion JPY | -14.73% |
| 2021 Q3 | 5.21 Billion JPY | 4.16% |
| 2021 Q4 | 6.7 Billion JPY | 28.6% |
| 2021 Q2 | 5 Billion JPY | -19.88% |
| 2020 Q4 | 5.57 Billion JPY | -34.48% |
| 2020 FY | 27.15 Billion JPY | 26.69% |
| 2020 Q1 | 7.49 Billion JPY | 4.09% |
| 2020 Q2 | 5.58 Billion JPY | -25.47% |
| 2020 Q3 | 8.5 Billion JPY | 52.44% |
| 2019 Q2 | 3.72 Billion JPY | -26.28% |
| 2019 Q1 | 5.04 Billion JPY | -15.54% |
| 2019 FY | 21.43 Billion JPY | 11.73% |
| 2019 Q4 | 7.19 Billion JPY | 31.6% |
| 2019 Q3 | 5.46 Billion JPY | 46.91% |
| 2018 Q4 | 5.97 Billion JPY | 42.27% |
| 2018 Q3 | 4.2 Billion JPY | 1.99% |
| 2018 Q1 | 4.88 Billion JPY | -15.18% |
| 2018 FY | 19.18 Billion JPY | 8.8% |
| 2018 Q2 | 4.12 Billion JPY | -15.66% |
| 2017 Q4 | 5.75 Billion JPY | 40.7% |
| 2017 FY | 17.63 Billion JPY | -3.2% |
| 2017 Q3 | 4.09 Billion JPY | 30.23% |
| 2017 Q1 | 4.63 Billion JPY | -17.71% |
| 2017 Q2 | 3.14 Billion JPY | -32.23% |
| 2016 Q4 | 5.63 Billion JPY | 44.66% |
| 2016 FY | 18.21 Billion JPY | 46.48% |
| 2016 Q3 | 3.89 Billion JPY | -4.25% |
| 2016 Q2 | 4.06 Billion JPY | -11.81% |
| 2016 Q1 | 4.61 Billion JPY | 42.72% |
| 2015 Q4 | 3.23 Billion JPY | 5.48% |
| 2015 Q3 | 3.06 Billion JPY | 10.77% |
| 2015 Q2 | 2.76 Billion JPY | -17.89% |
| 2015 Q1 | 3.37 Billion JPY | -4.69% |
| 2015 FY | 12.43 Billion JPY | 6.34% |
| 2014 FY | 11.69 Billion JPY | 10.32% |
| 2014 Q2 | 2.64 Billion JPY | -2.62% |
| 2014 Q3 | 2.8 Billion JPY | 5.98% |
| 2014 Q4 | 3.53 Billion JPY | 26.24% |
| 2014 Q1 | 2.71 Billion JPY | 8.0% |
| 2013 Q4 | 2.51 Billion JPY | 4.01% |
| 2013 Q3 | 2.41 Billion JPY | -5.25% |
| 2013 Q2 | 2.55 Billion JPY | -18.3% |
| 2013 Q1 | 3.12 Billion JPY | 36.95% |
| 2013 FY | 10.6 Billion JPY | 12.81% |
| 2012 Q4 | 2.27 Billion JPY | 12.54% |
| 2012 FY | 9.39 Billion JPY | 21.44% |
| 2012 Q1 | 2.96 Billion JPY | 44.92% |
| 2012 Q2 | 2.12 Billion JPY | -28.44% |
| 2012 Q3 | 2.02 Billion JPY | -4.66% |
| 2011 FY | 7.73 Billion JPY | 34.86% |
| 2011 Q3 | 1.69 Billion JPY | -2.8% |
| 2011 Q2 | 1.74 Billion JPY | -22.15% |
| 2011 Q1 | 2.24 Billion JPY | 30.54% |
| 2011 Q4 | 2.04 Billion JPY | 20.61% |
| 2010 Q2 | 1.23 Billion JPY | -15.78% |
| 2010 Q1 | 1.46 Billion JPY | 1.6% |
| 2010 Q3 | 1.32 Billion JPY | 7.06% |
| 2010 Q4 | 1.71 Billion JPY | 30.23% |
| 2010 FY | 5.73 Billion JPY | 21.75% |
| 2009 Q4 | 1.44 Billion JPY | 59.23% |
| 2009 FY | 4.71 Billion JPY | 65.86% |
| 2009 Q3 | 905 Million JPY | -31.02% |
| 2009 Q1 | 1.35 Billion JPY | 15.92% |
| 2009 Q2 | 1.31 Billion JPY | -3.1% |
| 2008 FY | 2.84 Billion JPY | 30.74% |
| 2008 Q2 | 692 Million JPY | 0.0% |
| 2008 Q3 | 672 Million JPY | -2.89% |
| 2008 Q4 | 1.16 Billion JPY | 73.81% |
| 2007 FY | 2.17 Billion JPY | -5.48% |
| 2006 FY | 2.29 Billion JPY | 18.26% |
| 2005 FY | 1.94 Billion JPY | 54.41% |
| 2004 FY | 1.25 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| HEARTSEED INC | -1.47 Billion JPY | 1759.586% |
| Cawachi Limited | 4.71 Billion JPY | -418.863% |
| Pharmarise Holdings Corporation | -351 Million JPY | 7066.952% |
| Qol Holdings Co., Ltd. | 4.88 Billion JPY | -401.107% |
| MatsukiyoCocokara & Co. | 52.34 Billion JPY | 53.285% |
| Welcia Holdings Co., Ltd. | 26.45 Billion JPY | 7.55% |
| Create SD Holdings Co., Ltd. | 13.69 Billion JPY | -78.614% |
| NIHON CHOUZAI Co.,Ltd. | 2.55 Billion JPY | -857.854% |
| Tsuruha Holdings Inc. | 24.1 Billion JPY | -1.448% |
| Ohki Healthcare Holdings Co.,Ltd. | 2.21 Billion JPY | -1006.516% |
| Satudora Holdings Co.,Ltd. | 470 Million JPY | -5102.979% |
| Kusuri No Aoki Holdings Co., Ltd. | 12.3 Billion JPY | -98.7% |
| Medical System Network Co., Ltd. | 1.86 Billion JPY | -1214.731% |
| Shinnihonseiyaku Co., Ltd. | 2.39 Billion JPY | -921.47% |
| Sugi Holdings Co.,Ltd. | 21.97 Billion JPY | -11.261% |
| YAKUODO HOLDINGS Co., Ltd. | 3.82 Billion JPY | -539.32% |
| Astena Holdings Co., Ltd. | 1.16 Billion JPY | -2003.128% |
| Genky DrugStores Co., Ltd. | 6.32 Billion JPY | -286.686% |
| Ain Holdings Inc. | 11.4 Billion JPY | -114.49% |
| Sundrug Co.,Ltd. | 29.12 Billion JPY | 16.041% |